Apolipoprotein A-IV restrains fat accumulation in skeletal and myocardial muscles by inhibiting lipogenesis and activating PI3K–AKT signalling

References

• Athyros, V.G., et al., 2018. Diabetes and lipid metabolism. Hormones, 17 (1), 61–67.
   PubMedGoogle Scholar
• Barazzoni, R., et al., 2018. Insulin resistance in obesity: an overview of fundamental alterations. Eating and weight disorders, 23 (2), 149–157.
   PubMed Web of Science ®Google Scholar
• Cătoi, A.F., et al., 2015. Metabolic mechanisms in obesity and type 2 diabetes: insights from bariatric/metabolic surgery. Obesity facts, 8 (6), 350–363.
   PubMed Web of Science ®Google Scholar
• Cheng, C., et al., 2022. Apolipoprotein A4 restricts diet-induced hepatic steatosis via SREBF1-mediated lipogenesis and enhances IRS–PI3K–Akt signaling. Molecular nutrition & food research, 66 (18), e2101034.
   PubMed Web of Science ®Google Scholar
• Davis, R.A.H., et al., 2017. High-intensity interval training and calorie restriction promote remodeling of glucose and lipid metabolism in diet-induced obesity. American journal of physiology. Endocrinology and metabolism, 313 (2), E243–E256.
   PubMed Web of Science ®Google Scholar
• Glatz, J.F.C., Dyck, J.R.B., and Des Rosiers, C., 2018. Cardiac adaptations to obesity, diabetes and insulin resistance. Biochimica et biophysica acta. Molecular basis of disease, 1864 (5 Pt B), 1905–1907.
   PubMed Web of Science ®Google Scholar
• Kachur, S., et al., 2017. Obesity and cardiovascular diseases. Minerva medica, 108 (3), 212–228.
   PubMed Web of Science ®Google Scholar
• Kohan, A.B., et al., 2015. ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety. American journal of physiology. Gastrointestinal and liver physiology, 308 (6), G472–G481.
   PubMed Web of Science ®Google Scholar
• Lazar, M.A., 2005. How obesity causes diabetes: not a tall tale. Science, 307 (5708), 373–375.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2014. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. Journal of biological chemistry, 289 (4), 2396–2404.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2017. ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K–Akt signaling. Scientific reports, 7, 41289.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2020. Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes. Journal of clinical investigation, 130 (6), 2992–3004.
   PubMed Web of Science ®Google Scholar
• Longo, M., et al., 2019. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International journal of molecular sciences, 20 (9), 2358.
   PubMed Web of Science ®Google Scholar
• Nishimura, K., et al., 2019. Circulating apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism. Scientific reports, 9 (1), 14869.
   PubMedGoogle Scholar
• Qu, J., et al., 2019. Apolipoprotein A-IV: a multifunctional protein involved in protection against atherosclerosis and diabetes. Cells, 8 (4), 319.
   PubMed Web of Science ®Google Scholar
• Smith, U., 2015. Abdominal obesity: a marker of ectopic fat accumulation. Journal of clinical investigation, 125 (5), 1790–1792.
   PubMed Web of Science ®Google Scholar
• Stegemann, R. and Buchner, D.A., 2015. Transgenerational inheritance of metabolic disease. Seminars in cell & developmental biology, 43, 131–140.
   PubMed Web of Science ®Google Scholar
• Tubb, M.R., et al., 2007. Modulation of apolipoprotein A-IV lipid binding by an interaction between the N and C termini. Journal of biological chemistry, 282 (39), 28385–28394.
   PubMed Web of Science ®Google Scholar
• VerHague, M.A., et al., 2013. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arteriosclerosis, thrombosis, and vascular biology, 33 (11), 2501–2508.
   PubMed Web of Science ®Google Scholar
• Wang, F., et al., 2012. Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proceedings of the national academy of sciences of the United States of America, 109 (24), 9641–9646.
   PubMed Web of Science ®Google Scholar
• Wang, F., et al., 2015. Apolipoprotein A-IV: a protein intimately involved in metabolism. Journal of lipid research, 56 (8), 1403–1418.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2010. Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Molecular therapy, 18 (1), 118–125.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2021. Apolipoprotein A4 regulates the immune response in carbon tetrachloride-induced chronic liver injury in mice. International immunopharmacology, 90, 107222.
   PubMed Web of Science ®Google Scholar
• Woting, A., et al., 2014. Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio, 5 (5), e01530-14.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2020. Leucine decreases intramyocellular lipid deposition in an mTORC1-independent manner in palmitate-treated C2C12 myotubes. American journal of physiology. Endocrinology and metabolism, 318 (2), E152–E163.
   PubMed Web of Science ®Google Scholar
• Xu, B., et al., 2017. The effect of sitagliptin on lipid metabolism of fatty liver mice and related mechanisms. Medical science monitor, 23, 1363–1370.
   PubMed Web of Science ®Google Scholar
• Xu, X.R., et al., 2018. Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis. Nature communications, 9 (1), 3608.
   PubMedGoogle Scholar
• Yazıcı, D. and Sezer, H., 2017. Insulin resistance, obesity and lipotoxicity. Advances in experimental medicine and biology, 960, 277–304.
   PubMed Web of Science ®Google Scholar
• Yecies, J.L., et al., 2011. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell metabolism, 14 (1), 21–32.
   PubMed Web of Science ®Google Scholar
• Yi, J., et al., 2020. Oncogenic activation of PI3K–AKT–mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proceedings of the national academy of sciences of the United States of America, 117 (49), 31189–31197.
   PubMed Web of Science ®Google Scholar
• Yu, H., et al., 2019. Dietary bile acids enhance growth, and alleviate hepatic fibrosis induced by a high starch diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 pathway in Micropterus salmoides. Frontiers in physiology, 10, 1430.
   PubMed Web of Science ®Google Scholar
• Yu, Y., et al., 2018. Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARγ. Theranostics, 8 (8), 2171–2188.
   PubMed Web of Science ®Google Scholar
• Zhang, B., et al., 2022. Aquaporin-9 facilitates liver regeneration following hepatectomy. Redox biology, 50, 102246.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., et al., 2019. Tangduqing granules attenuate insulin resistance and abnormal lipid metabolism through the coordinated regulation of PPARγ and DGAT2 in type 2 diabetic rats. Journal of diabetes research, 2019, 7403978.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2017. Effect of ApoA4 on SERPINA3 mediated by nuclear receptors NR4A1 and NR1D1 in hepatocytes. Biochemical and biophysical research communications, 487 (2), 327–332.
   PubMed Web of Science ®Google Scholar
• Zhao, L., et al., 2018. CD36 and lipid metabolism in the evolution of atherosclerosis. British medical bulletin, 126 (1), 101–112.
   PubMed Web of Science ®Google Scholar